Global PD-L1 And PIK3CA Testing Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

PD-L1 And PIK3CA Testing Global Market Report 2025

Name: PD-L1 And PIK3CA Testing Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Test Type (Immunohistochemistry, Next-Generation Sequencing, Polymerase Chain Reaction, Other Test Types); By Sample Type (Tissue Samples, Liquid Biopsy Samples); By Distribution Channel (Direct Sales, Distributors And Resellers, Online Sales Platforms); By Applications (Cancer Diagnosis, Drug Development, Research, Other Applications); By End User (Hospitals And Clinics, Laboratories, Pharmaceutical Companies); Subsegments:; By Immunohistochemistry (Tissue Staining, Protein Expression Analysis, Tumor Microenvironment Assessment); By Next-Generation Sequencing (Whole Genome Sequencing); By Polymerase Chain Reaction (Digital Polymerase Chain Reaction); By Other Test Types (In Situ Hybridization (ISH)) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

PD-L1 And PIK3CA Testing Market Overview

• PD-L1 And PIK3CA Testing market size has reached to $1.45 billion in 2024

• Expected to grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%

• Growth Driver: Increasing Prevalence Of Cancer Is Fueling The Growth Of The Market Due To Rising Diagnosis Rates And Growing Demand For Targeted Treatments

• Market Trend: Advancements In Precision Oncology Through Companion Diagnostic Integration

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under PD-L1 And PIK3CA Testing Market?

PD-L1 and PIK3CA testing are molecular diagnostic procedures used to identify specific biomarkers that guide targeted cancer treatment decisions. PD-L1 testing evaluates the expression of the programmed death-ligand 1 protein on tumor cells to determine potential response to immunotherapies. PIK3CA testing detects mutations in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha gene, helping to assess eligibility for therapies targeting the PI3K pathway.

The main test types of PD-L1 and PIK3CA testing are immunohistochemistry, next-generation sequencing, polymerase chain reaction, and others. Immunohistochemistry is a laboratory technique that uses antibodies to detect specific proteins in tissue samples, allowing visualization of their location and abundance under a microscope. The different sample types are tissue samples and liquid biopsy samples. The multiple distribution channels are direct sales, distributors and resellers, and online sales platforms. The various applications involved are cancer diagnosis, drug development, research, and others, and they are used by several end users such as hospitals and clinics, laboratories, and pharmaceutical companies.

PD-L1 And PIK3CA Testing Market Size and growth rate 2025 to 2029: Graph

What Is The PD-L1 And PIK3CA Testing Market Size 2025 And Growth Rate?

What Is The PD-L1 And PIK3CA Testing Market Growth Forecast?

The PD-L1 and PIK3CA testing market size is expected to see rapid growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to growing adoption of personalized and precision medicine, expanding pipeline of cell and gene therapies, increase in clinical trials and commercial approvals, growing investment in regenerative medicine, and rising incidence of chronic and rare diseases. Major trends in the forecast period include development of bioinformatics in cellular research, integration of cell therapy tracking with digital health platforms, advancement of artificial intelligence (AI) and machine learning integration, innovation in cloud-based data management systems, and integration of wearable biosensors.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How the PD-L1 And PIK3CA Testing Market Segmented?

1) By Test Type: Immunohistochemistry, Next-Generation Sequencing, Polymerase Chain Reaction, Other Test Types

2) By Sample Type: Tissue Samples, Liquid Biopsy Samples

3) By Distribution Channel: Direct Sales, Distributors And Resellers, Online Sales Platforms

4) By Applications: Cancer Diagnosis, Drug Development, Research, Other Applications

5) By End User: Hospitals And Clinics, Laboratories, Pharmaceutical Companies

Subsegments:

1) By Immunohistochemistry: Tissue Staining, Protein Expression Analysis, Tumor Microenvironment Assessment

2) By Next-Generation Sequencing: Whole Genome Sequencing, Targeted Gene Sequencing, Exome Sequencing, Ribonucleic Acid (RNA) Sequencing

3) By Polymerase Chain Reaction: Quantitative Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction

4) By Other Test Types: In Situ Hybridization (ISH), Sanger Sequencing, Flow Cytometry, Microarray-Based Assays

What Is Driving The PD-L1 And PIK3CA Testing Market? Increasing Prevalence Of Cancer Is Fueling The Growth Of The Market Due To Rising Diagnosis Rates And Growing Demand For Targeted Treatments

The increasing prevalence of cancer is expected to propel the growth of the PD-L1 and PIK3CA testing market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body, that can invade surrounding tissues and potentially metastasize to other parts. The cancer prevalence is due to growing lifestyle-related risks and aging populations that are leading to higher diagnosis rates and greater demand for early detection and effective treatment solutions. PD-L1 and PIK3CA testing support the management of cancer by allowing for exact diagnosis and guiding targeted medicines, which help adapt treatment regimens to individual patients and improve clinical outcomes. For instance, in September 2024, according to the American Cancer Society, a US-based non-profit organization, global cancer cases in men is expected to rise by 84% by 2029, increasing from 10.3 million in 2022 to 19 million. Therefore, increasing prevalence of cancer is driving the growth of the PD-L1 and PIK3CA testing industry.

Who Are The Major Players In The Global PD-L1 And PIK3CA Testing Market?

Major companies operating in the PD-L1 and PIK3CA testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., NeoGenomics Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences, Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., ACCB Biotech Private Limited, EntroGen Inc.

What Are The Key Trends Of The Global PD-L1 And PIK3CA Testing Market? Advancements In Precision Oncology Through Companion Diagnostic Integration

Major companies operating in the PD-L1 and PIK3CA testing market are focusing on technological advancements, such as companion diagnostic integration, to improve therapeutic targeting, enhance treatment efficacy, and support personalized medicine approaches in oncology. Companion diagnostic integration refers to enhanced, technology-driven testing systems designed in conjunction with targeted medicines to identify patient populations most likely to benefit from specific treatments based on biomarker profiles. For instance, in October 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and pharmaceutical company, launched Itovebi (inavolisib) in combination with palbociclib and fulvestrant for adults with endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative advanced or metastatic breast cancer. The Food and Drug Administration (FDA), a US-based federal agency, approved the regimen, based on the pivotal Phase III INAVO120 study, that more than doubled progression-free survival compared with palbociclib and fulvestrant alone, represents Roche’s first targeted therapy for HR-positive disease, and integrates a companion diagnostic to identify eligible patients, marking a significant advancement in precision medicine for a patient population with limited first-line treatment options.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The PD-L1 And PIK3CA Testing Market? Toulouse University Hospital Acquires Epione Robot From Quantum Surgical To Enhance Minimally Invasive Cancer Treatments

In December 2022, Prenetics Global Limited, a Hong Kong-based health-focused technology company, acquired ACT Genomics Co. Ltd. for an undisclosed amount. Through this acquisition, Prenetics aims to expand its presence in the precision oncology market by integrating ACT Genomics’ advanced capabilities in next-generation sequencing (NGS), bioinformatics, and comprehensive genomic profiling. ACT Genomics Co. Ltd., a Taiwan-based molecular diagnostics company offering PD-L1 and PIK3CA biomarker testing for cancer treatment guidance.

What Is The Regional Outlook For The Global PD-L1 And PIK3CA Testing Market?

North America was the largest region in the PD-L1 and PIK3CA testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the PD-L1 And PIK3CA Testing Market?

The PD-L1 and PIK3CA testing market includes revenues earned by entities through the biomarker testing, molecular diagnostics, genetic mutation detection, generation sequencing services, companion diagnostic testing, pathology interpretation, and clinical trial testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the PD-L1 And PIK3CA Testing Industry?

The pd-l1 and pik3ca testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pd-l1 and pik3ca testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

1. Executive Summary

2. PD-L1 And PIK3CA Testing Market Characteristics

3. PD-L1 And PIK3CA Testing Market Trends And Strategies

4. PD-L1 And PIK3CA Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global PD-L1 And PIK3CA Testing Growth Analysis And Strategic Analysis Framework

5.1. Global PD-L1 And PIK3CA Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global PD-L1 And PIK3CA Testing Market Growth Rate Analysis

5.4. Global PD-L1 And PIK3CA Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global PD-L1 And PIK3CA Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global PD-L1 And PIK3CA Testing Total Addressable Market (TAM)

6. PD-L1 And PIK3CA Testing Market Segmentation

6.1. Global PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunohistochemistry

Next-Generation Sequencing

Polymerase Chain Reaction

Other Test Types

6.2. Global PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tissue Samples

Liquid Biopsy Samples

6.3. Global PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Direct Sales

Distributors And Resellers

Online Sales Platforms

6.4. Global PD-L1 And PIK3CA Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer Diagnosis

Drug Development

Research

Other Applications

6.5. Global PD-L1 And PIK3CA Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Laboratories

Pharmaceutical Companies

6.6. Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tissue Staining

Protein Expression Analysis

Tumor Microenvironment Assessment

6.7. Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Genome Sequencing

Targeted Gene Sequencing

Exome Sequencing

Ribonucleic Acid (RNA) Sequencing

6.8. Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Quantitative Polymerase Chain Reaction

Reverse Transcription Polymerase Chain Reaction

Digital Polymerase Chain Reaction

6.9. Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In Situ Hybridization (ISH)

Sanger Sequencing

Flow Cytometry

Microarray-Based Assays

7. PD-L1 And PIK3CA Testing Market Regional And Country Analysis

7.1. Global PD-L1 And PIK3CA Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global PD-L1 And PIK3CA Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific PD-L1 And PIK3CA Testing Market

8.1. Asia-Pacific PD-L1 And PIK3CA Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China PD-L1 And PIK3CA Testing Market

9.1. China PD-L1 And PIK3CA Testing Market Overview

9.2. China PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India PD-L1 And PIK3CA Testing Market

10.1. India PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan PD-L1 And PIK3CA Testing Market

11.1. Japan PD-L1 And PIK3CA Testing Market Overview

11.2. Japan PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia PD-L1 And PIK3CA Testing Market

12.1. Australia PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia PD-L1 And PIK3CA Testing Market

13.1. Indonesia PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea PD-L1 And PIK3CA Testing Market

14.1. South Korea PD-L1 And PIK3CA Testing Market Overview

14.2. South Korea PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe PD-L1 And PIK3CA Testing Market

15.1. Western Europe PD-L1 And PIK3CA Testing Market Overview

15.2. Western Europe PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK PD-L1 And PIK3CA Testing Market

16.1. UK PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany PD-L1 And PIK3CA Testing Market

17.1. Germany PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France PD-L1 And PIK3CA Testing Market

18.1. France PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy PD-L1 And PIK3CA Testing Market

19.1. Italy PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain PD-L1 And PIK3CA Testing Market

20.1. Spain PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe PD-L1 And PIK3CA Testing Market

21.1. Eastern Europe PD-L1 And PIK3CA Testing Market Overview

21.2. Eastern Europe PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia PD-L1 And PIK3CA Testing Market

22.1. Russia PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America PD-L1 And PIK3CA Testing Market

23.1. North America PD-L1 And PIK3CA Testing Market Overview

23.2. North America PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA PD-L1 And PIK3CA Testing Market

24.1. USA PD-L1 And PIK3CA Testing Market Overview

24.2. USA PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada PD-L1 And PIK3CA Testing Market

25.1. Canada PD-L1 And PIK3CA Testing Market Overview

25.2. Canada PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America PD-L1 And PIK3CA Testing Market

26.1. South America PD-L1 And PIK3CA Testing Market Overview

26.2. South America PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil PD-L1 And PIK3CA Testing Market

27.1. Brazil PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East PD-L1 And PIK3CA Testing Market

28.1. Middle East PD-L1 And PIK3CA Testing Market Overview

28.2. Middle East PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa PD-L1 And PIK3CA Testing Market

29.1. Africa PD-L1 And PIK3CA Testing Market Overview

29.2. Africa PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. PD-L1 And PIK3CA Testing Market Competitive Landscape And Company Profiles

30.1. PD-L1 And PIK3CA Testing Market Competitive Landscape

30.2. PD-L1 And PIK3CA Testing Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Laboratory Corporation of America Holdings (Labcorp) Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. PD-L1 And PIK3CA Testing Market Other Major And Innovative Companies

31.1. Eurofins Scientific SE

31.2. Agilent Technologies Inc.

31.3. Sonic Healthcare Limited

31.4. Illumina Inc.

31.5. Bio-Rad Laboratories Inc.

31.6. QIAGEN N.V.

31.7. Myriad Genetics Inc.

31.8. NeoGenomics Laboratories Inc.

31.9. BGI Genomics Co. Ltd.

31.10. Guardant Health Inc.

31.11. Caris Life Sciences

31.12. Foundation Medicine Inc.

31.13. Amoy Diagnostics Co. Ltd.

31.14. ACCB Biotech Private Limited

31.15. EntroGen Inc.

32. Global PD-L1 And PIK3CA Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The PD-L1 And PIK3CA Testing Market

34. Recent Developments In The PD-L1 And PIK3CA Testing Market

35. PD-L1 And PIK3CA Testing Market High Potential Countries, Segments and Strategies

35.1 PD-L1 And PIK3CA Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 PD-L1 And PIK3CA Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 PD-L1 And PIK3CA Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global PD-L1 And PIK3CA Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global PD-L1 And PIK3CA Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global PD-L1 And PIK3CA Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global PD-L1 And PIK3CA Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: F. Hoffmann-La Roche AG Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: Abbott Laboratories Financial Performance

Table 83: Laboratory Corporation of America Holdings (Labcorp) Financial Performance

Table 84: Quest Diagnostics Incorporated Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global PD-L1 And PIK3CA Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global PD-L1 And PIK3CA Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global PD-L1 And PIK3CA Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global PD-L1 And PIK3CA Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global PD-L1 And PIK3CA Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, PD-L1 And PIK3CA Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, PD-L1 And PIK3CA Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, PD-L1 And PIK3CA Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: F. Hoffmann-La Roche AG Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: Abbott Laboratories Financial Performance

Figure 83: Laboratory Corporation of America Holdings (Labcorp) Financial Performance

Figure 84: Quest Diagnostics Incorporated Financial Performance

Future Projections: Oxygen Source Equipment Market to Reach $5.87 Billion by 2029 at 10.3% CAGR

2025–2029 Peripheral Interventions Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Personal Protective Equipment For Infection Control Market to 2029

Comprehensive Forecast: Personalized Cranial Implant Market Share, Growth, and Opportunities Through 2029

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

HPV Testing And Pap Test Global Market Report 2025 – By Test Type (HPV Testing, Pap Test), By Product (Instruments, Consumables, Services), By Technology (Polymerase Chain Reaction (PCR), Immunodiagnostics, Other Technol...

D Dimer Testing Global Market Report 2025 – By Test (Clinical Laboratory Tests, Point-Of-Care Tests), By Product (Analyzers, Reagents And Consumables), By Method (Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced...

Direct-To-Consumer (DTC) Laboratory Testing Global Market Report 2025 – By Sample Type (Blood, Urine, Saliva, Other Sample Types), By Test Type (Genetic Testing, Disease Risk Assessment Testing, Complete Blood Count (CBC...

Minimal Residual Disease Testing Global Market Report 2025 – By Test Type (DNA - Based Test, RNA- Based Test, Immunological Test), By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencin...

Laboratory Proficiency Testing Global Market Report 2025 – By Technology (Cell Culture, PCR, Immunoassays, Chromatography, Spectrophotometry, Other Technologies), By Test (Routine, Specialty), By Department (Parasitology...

Companion Diagnostics Global Market Report 2025 – By Product And Service (Assays, Kits And Reagents, Software And Services), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Im...

Testing Software Global Market Report 2025 – By Type (System Integrator, Pureplay Testing Software), By Component (Application Testing, Services), By End-User (BFSI (Banking, Financial Service and Insurance), IT (Informa...

Frequently Asked Questions

What is the definition of the PD-L1 And PIK3CA Testing market?

How will the PD-L1 And PIK3CA Testing market drivers and restraints affect the market dynamics? What forces will shape the PD-L1 And PIK3CA Testing industry going forward?

The market major growth driver - Increasing Prevalence Of Cancer Is Fueling The Growth Of The Market Due To Rising Diagnosis Rates And Growing Demand For Targeted Treatments. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the PD-L1 And PIK3CA Testing market?

The PD-L1 and PIK3CA testing market size has grown rapidly in recent years. It will grow from $1.45 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to rise in clinical trials for regenerative medicine, growing focus on personalized medicine, expansion of academic and industry collaborations, increasing awareness of cell therapy efficacy and safety, and rapid growth and first approvals of car-t and other autologous cell therapies. The PD-L1 and PIK3CA testing market size is expected to see rapid growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to growing adoption of personalized and precision medicine, expanding pipeline of cell and gene therapies, increase in clinical trials and commercial approvals, growing investment in regenerative medicine, and rising incidence of chronic and rare diseases. Major trends in the forecast period include development of bioinformatics in cellular research, integration of cell therapy tracking with digital health platforms, advancement of artificial intelligence (AI) and machine learning integration, innovation in cloud-based data management systems, and integration of wearable biosensors. For further insights on this market, request a sample here

How is the PD-L1 And PIK3CA Testing market segmented?

The pd-l1 and pik3ca testing market covered in this report is segmented as
1) By Test Type: Immunohistochemistry, Next-Generation Sequencing, Polymerase Chain Reaction, Other Test Types
2) By Sample Type: Tissue Samples, Liquid Biopsy Samples
3) By Distribution Channel: Direct Sales, Distributors And Resellers, Online Sales Platforms
4) By Applications: Cancer Diagnosis, Drug Development, Research, Other Applications
5) By End User: Hospitals And Clinics, Laboratories, Pharmaceutical Companies Subsegments:
1) By Immunohistochemistry: Tissue Staining, Protein Expression Analysis, Tumor Microenvironment Assessment
2) By Next-Generation Sequencing: Whole Genome Sequencing, Targeted Gene Sequencing, Exome Sequencing, Ribonucleic Acid (RNA) Sequencing
3) By Polymerase Chain Reaction: Quantitative Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction
4) By Other Test Types: In Situ Hybridization (ISH), Sanger Sequencing, Flow Cytometry, Microarray-Based Assays For further insights on this market, request a sample here

Which region has the largest share of the PD-L1 And PIK3CA Testing market? What are the other regions covered in the report?

North America was the largest region in the PD-L1 and PIK3CA testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in PD-L1 and PIK3CA testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the PD-L1 And PIK3CA Testing market?

What are the key trends in the PD-L1 And PIK3CA Testing market?

Major trends in this market include Advancements In Precision Oncology Through Companion Diagnostic Integration For further insights on this market, request a sample here.